Medtronic, the Minnesota-based company that pioneered devices to repair the heart, is investing $24 million to enter the business of serving patients with kidney disease and failure, with a focus on the developing world.
The Star Tribune said the deal involves a joint venture with one of India’s largest health care systems. Bloomberg News reports that Medtronic will collaborate with Apollo Hospitals Enterprise on a new approach to hemodialysis, which filters toxins from the blood of people with kidneys too damaged to do the job.
The companies will work to develop a low-cost, portable approach. Patients with late-stage kidney disease in the developing world are less likely to have access to dialysis, and need options that don’t require as much water and infrastructure. Medtronic said it hopes to market a laptop-sized dialysis device for small communities or home use by 2016..
About 10 percent of adults in India have kidney disease.